BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Mulholland K. Evaluation of vaccines to prevent childhood pneumonia: lessons relevant to planning tuberculosis vaccine trials. Clin Infect Dis 2000 Jun;30
Suppl 3:S206­9.
Munoz FM, Englund JA. A step ahead. Infant protection through maternal immunization. Pediatr Clin North Am 2000; 47(2):449­463.
Munoz FM, Galasso GJ, Gwaltney JM Jr, Hayden FG, Murphy B, Webster R, Wright P, Couch RB. Current research on influenza and other respiratory
viruses: II international symposium. Antiviral Res 2000 May;46(2):91­124.
Murphy LA, Buckley C. Gianotti­Crosti syndrome in an infant following immunization. Pediatr Dermatol 2000 May­2000 Jun 30;17(3):225­6.
Murphy LA, Buckley C. Gianotti­Crosti syndrome in an infant following immunization. Pediatr Dermatol 2000 May­Jun;17(3):225­6.
Murphy, E. Hepatitis B, vaccination and healthcare workers. Occup Med (Lond) 2000 Aug;50(6):383­6
Murray KO, Arguin PM. Decision­based evaluation of recommendations for preexposure rabies vaccination. J.Am.Vet.Med.Assoc. 2000;188­91.
Murray M, Rasmussen Z. Measles outbreak in a northern Pakistani village: epidemiology and vaccine effectiveness. Am J Epidemiol 2000 Apr 15;151(8):811­
9.
Myers RP, Gregor JC, Marotta PJ. The cost­effectiveness of hepatitis A vaccination in patients with chronic hepatitis C. Hepatology 2000; 31(4):834­839.
Nabors GS, Braun PA, Herrmann DJ, Heise ML, Pyle DJ, Gravenstein S et al. Immunization of healthy adults with a single recombinant pneumococcal
surface protein A (PspA) variant stimulates broadly cross­reactive antibodies to heterologous PspA molecules. Vaccine 2000; 18(17):1743­1754.
Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction.
Circulation (Online) 2000 Dec 19;102(25):3039­45
Naniche D, Yeh A, Eto D, Manchester M, Friedman RM, Oldstone MB. Evasion of host defenses by measles virus: wild­type measles virus infection
interferes with induction of Alpha/Beta interferon production. J Virol 2000 Aug;74(16):7478­84.
Nasir L. Reconnoitering the antivaccination web sites: news from the front. J Fam Pract 2000 Aug;49(8):731­3.
Nasir, K., Khan, K. A., Kadri, W. M., Salim, S., Tufail, K., Sheikh, H. Z., and Ali, S. A. Hepatitis B vaccination among health care workers and students of a
medical college. JPMA J Pak Med Assoc 2000 Jul;50(7):239­43
Nasr JT, Andriola MR, Coyle PK. ADEM: literature review and case report of acute psychosis presentation. Pediatr Neurol 2000 Jan;22(1):8­18.
Nassif X. Microbiology. A furtive pathogen revealed [comment]. Science 2000; 287(5459):1767­1768.
National, state, and urban area vaccination coverage levels among children aged 19­35 months­­United States, 1999. MMWR Morb Mortal Wkly Rep 2000 Jul
7;49(26):585­9.
Nekrassova LS, Chudnaya LM, Marievski VF, Oksiuk VG, Gladkaya E, Bortnitska II et al. Epidemic diphtheria in Ukraine, 1991­1997. J Infect Dis 2000; 181
Suppl 1:S35­S40.
Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Jr., Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in
children [see comments]. N.Engl.J.Med. 2000;225­31.
Nicholson KG. Should staff in long­stay hospitals for elderly patients be vaccinated against influenza? [comment]. Lancet 2000;83­4.
Nicolay, U., Girgsdies, O. E., Banzhoff, A., Hundt, E., Kondler­Budde, R., Lober, R., Hainz, R., and Jilg, W. [Diphtheria antitoxin level 2 years after booster
vaccination] Wien.Med.Wochenschr. 2000, 150 (22): 435­439.
Nielsen C. Coping with vaccine manufacturing delays. Cleve Clin J Med 2000 Dec;67(12):898­900, 902
Niyazmatov BI, Shefer A, Grabowsky M, Vitek CR. Diphtheria epidemic in the Republic of Uzbekistan, 1993­1996. J Infect Dis 2000; 181 Suppl 1:S104­
S109.
Nolan P. Primary care: the backbone of prevention. Med.Health R.I. 2000;7­8.
Nordstrand A, Barbour AG, Bergstrom S. Borrelia pathogenesis research in the post­genomic and post­vaccine era. Curr Opin Microbiol 2000; 3(1):86­92.
Nossal GJ. Vaccination and autoimmunity. J.Autoimmun. 2000;13­5.
Obaro SK. Prospects for pneumococcal vaccination in African children. Acta Trop 2000; 75(2):141­153.
Offit, P. Maintaining the public's trust in immunizations. Del Med J 2000 Aug;72(8):361­5
Ohgaki H, Huang H, Haltia M, Vainio H, Kleihues P. More about: cell and molecular biology of simian virus 40: implications for human infections and
disease [letter]. J Natl Cancer Inst 2000; 92(6):495­497.
Ohsaki M, Tsutsumi H, Takeuchi R, Seki K, Chiba S. Recent increase in the frequency of infant measles in Japan. Pediatr Int 2000 Jun;42(3):233­5.
Olin P. Direct and indirect protection from Hib disease: may immunization of a target group lead to eradication of the disease in a population? [comment].
Acta Paediatr 2000 Apr;89(4):394­7.
Olowokure, B., Hawker, J., Blair, I., and Spencer, N. Decrease in effectiveness of routine surveillance of Haemophilus influenzae disease after introduction of
conjugate vaccine: comparison of routine reporting with active surveillance system. BMJ 2000 Sep 23;321(7263):731­2
Opare C, Nsiire A, Awumbilla B, Akanmori BD. Human behavioural factors implicated in outbreaks of human anthrax in the Tamale municipality of northern
Ghana. Acta Trop 2000 Jul 21;76(1):49­52.
Orenstein, W. A., Strebel, P. M., Papania, M., Sutter, R. W., Bellini, W. J., and Cochi, S. L. Measles eradication: is it in our future? Am J Public Health 2000
Oct;90(10):1521­5
Ormerod LP. BCG vaccination by multipuncture method [letter]. Thorax 2000; 55(4):345.
Ortega AN, Stewart DC, Dowshen SA, Katz SH. The impact of a pediatric medical home on immunization coverage. Clin.Pediatr.(Phila) 2000;89­96.
Overturf GD. American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use
of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 2000 Aug;106(2 Pt 1):367­76.
Paas­Rozner M, Dayan M, Paas Y, Changeux JP, Wirguin I, Sela M et al. Oral administration of a dual analog of two myasthenogenic T cell epitopes downregulates
experimental autoimmune myasthenia gravis in mice. Proc Natl Acad Sci U S A 2000; 97(5):2168­2173.
Paganini H, Gonzalez F, Santander C, Casimir L, Berberian G, Rosanova MT. Tuberculous meningitis in children: clinical features and outcome in 40 cases.
Scand J Infect Dis 2000; 32(1):41­45.
Page D, Eason P, Humiston S, Barker W. Notes from the Association of Teachers of Preventive Medicine: vaccine risk/ benefit communication project.
Am.J.Prev.Med. 2000;176­7.
Page, R. C. Vaccination and Periodontitis: Myth or Reality. J Int.Acad.Periodontol. 2000, 2 (2): 31­43.
Pandey P, Cave W, Shlim DR. Hepatitis A post hepatitis A vaccination? J Travel Med. 2000 Jul­Aug;7(4):213­4.
Paneth N, Kort EJ, Jurczak D, Havlichek DA Jr, Braunlich K, Moorer G, Vanderjagt D, Sienko D, Leiby P, Gibbons C. Predictors of vaccination rates during a
mass meningococcal vaccination program on a college campus. J Am Coll Health 2000 Jul;49(1):7­11.
Parashar UD, Holman RC, Cummings KC, Staggs NW, Curns AT, Zimmerman CM, Kaufman SF, Lewis JE, Vugia DJ, Powell KE, et al. Trends in
intussusception­associated hospitalizations and deaths among US infants. Pediatrics 2000 Dec;106(6):1413­21
Pareek, M. and Pattison, H. M. The two­dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate
Br.J.Gen.Pract. 2000, 50 (461): 969­971.
Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H. Serious adverse events after measles­mumps­rubella vaccination during a fourteen­year
prospective follow­up. Pediatr Infect Dis J 2000 Dec;19(12):1127­34
Patterson JB, Thomas D, Lewicki H, Billeter MA, Oldstone MB. V and C proteins of measles virus function as virulence factors in vivo. Virology 2000;80­9.
Patti AM, Santi AL, Fiore L, Vellucci L, De Stefano D, Bellelli E, Barbuti S, Fara GM; The Study Group. Enterovirus surveillance of Italian healthy children.
Eur J Epidemiol 2000;16(11):1035­8.
Pauksen K, Linde A, Hammarstrom V, Sjolin J, Carneskog J, Jonsson G et al. Granulocyte­macrophage colony­stimulating factor as immunomodulating factor
together with influenza vaccination in stem cell transplant patients. Clin Infect Dis 2000; 30(2):342­348.